(Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome

European Journal of Human Genetics

Volumn 24, Issue 2, 2016, Pages 183-190

  Mussa, Alessandro ^a   Russo, Silvia ^b   De Crescenzo, Agostina ^c   Freschi, Andrea ^c   Calzari, Luciano ^b   Maitz, Silvia ^d   Macchiaiolo, Marina ^e   Molinatto, Cristina ^a   Baldassarre, Giuseppina ^a   Mariani, Milena ^d   Tarani, Luigi ^f   Bedeschi, Maria Francesca ^g   Milani, Donatella ^h   Melis, Daniela ⁱ   Bartuli, Andrea ^e   Cubellis, Maria Vittoria ⁱ   Selicorni, Angelo ^d   Cirillo Silengo, Margherita ^a   Larizza, Lidia ^b,j   Riccio, Andrea ^c,k   Ferrero, Giovanni Battista ^a   more..

^a UNIVERSITY OF TURIN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^j UNIVERSITY OF MILAN   (Italy)

^k INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; CDKN1C PROTEIN, HUMAN;

ABDOMINAL WALL DEFECT; ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; BECKWITH WIEDEMANN SYNDROME; BENIGN TUMOR; CANCER RISK; CANCER SCREENING; CAVERNOUS HEMANGIOMA; CHILD; CHROMOSOME 11P; CHROMOSOME 11P15; CLEFT PALATE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE SEVERITY; DNA METHYLATION; EAR MALFORMATION; EPIGENETICS; FOLLOW UP; GENE LOSS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GERM CELL TUMOR; HEMANGIOTELIOMA; HEMIHYPERTROPHY; HEPATOBLASTOMA; HUMAN; HYDRAMNIOS; INCIDENCE; INFANT; INFERTILITY THERAPY; ITALY; KIDNEY MALFORMATION; LIPOMA; LIVER HEMANGIOMA; MACROGLOSSIA; MACROSOMIA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MAMMARY GLAND FIBROMA; NEPHROBLASTOMA; NEUROBLASTOMA; NEVUS FLAMMEUS; OMPHALOCELE; PANCREATOBLASTOMA; PATHOGENICITY; PILOMATRIXOMA; PREMATURE LABOR; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID ADENOMA; TUMOR DIAGNOSIS; UMBILICAL HERNIA; UNIPARENTAL DISOMY; URETHRA MALFORMATION; URINARY TRACT INFECTION; CHROMOSOME 11; COMPLICATION; FEMALE; GENETIC ASSOCIATION STUDY; GENETICS; GENOME IMPRINTING; GENOTYPE; MALE; NEOPLASMS; PATHOLOGY; PHENOTYPE;

BECKWITH-WIEDEMANN SYNDROME; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION STUDIES; GENOMIC IMPRINTING; GENOTYPE; HUMANS; MALE; NEOPLASMS; PHENOTYPE;

EID: 84954404387     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2015.88     Document Type: Article

References (47)

1. Mussa A, Russo S, De Crescenzo A et al: Prevalence of Beckwith-Wiedemann syndrome in North West of Italy. Am J Med Genet A 2013; 161: 2481-2486.
2. Shuman C, Beckwith JB, Smith AC, Weksberg R: Beckwith-Wiedemann Syndrome; in Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (eds): GeneReviews. Seattle (WA), University of Washington: Seattle, 1993-2013.
3. Weksberg R, Shuman C, Beckwith JB: Beckwith-Wiedemann syndrome. Eur J Hum Genet 2010; 18: 8-14.
4. Rump P, Zeegers MP, van Essen AJ: Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis. Am J Med Genet A 2005; 136: 95-104.
5. Choufani S, Shuman C, Weksberg R: Molecular findings in Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2013; 163C: 131-140.
6. Eggermann T, Algar E, Lapunzina P et al: Clinical utility gene card for: Beckwith-WiedemannaSyndrome. Eur J Hum Genet 2014; 22; doi:10.1038/ejhg.2013.132.
7. Zimmerman DL, Boddy CS, Schoenherr CS: Oct4/Sox2 binding sites contribute to maintaining hypomethylation of the maternal igf2/h19 imprinting control region. PLoS One 2013; 8: e81962.
8. Abi Habib W, Azzi S, Brioude F et al: Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome. Hum Mol Genet 2014; 23: 5763-5773.
9. Cooper WN, Luharia A, Evans GA et al: Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2005; 13: 1025-1032.
10. Brioude F, Lacoste A, Netchine I et al: Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance. Horm Res Paediatr 2013; 80: 457-465.
11. Mussa A, Peruzzi L, Chiesa N et al: Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome. Pediatr Nephrol 2012; 27: 397-406.
12. Choufani S, Shuman C, Weksberg R: Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2010; 154C: 343-354.
13. Ibrahim A, Kirby G, Hardy C et al: Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjects. Clin Epigenetics 2014; 6: 11.
14. Bertino E, Spada E, Occhi L et al: Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr 2010; 51: 353-361.
15. Alders M, Bliek J, vd Lip K, vd Bogaard R, Mannens M: Determination of KCNQ1OT1 and H19 methylation levels in BWS and SRS patients using methylation-sensitive high-resolution melting analysis. Eur J Hum Genet 2009; 17: 467-473.
16. Priolo M, Sparago A, Mammì C et al: MS-MLPAisaspecific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment. Eur J Hum Genet 2008; 16: 565-571.
17. Bliek J, Verde G, Callaway J et al: Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. Eur J Hum Genet 2009; 17: 611-619.
18. Russo S, Mencarelli M, Cavalleri F et al: Afluorescent method for detecting low-grade 11patUPD mosaicism in Beckwith-Wiedemann syndrome. Mol Cell Probes 2003; 17: 295-299.
19. Romanelli V, Belinchón A, Benito-Sanz S et al: CDKN1C (p57(Kip2)) analysis in Beckwith-Wiedemann syndrome (BWS) patients: Genotype-phenotype correlations, novel mutations, and polymorphisms. Am J Med Genet A 2010; 152A: 1390-1397.
20. Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT: LOVD v.2.0: the next generation in gene variant databases. Hum Mutat 2011; 32: 557-563.
21. Chiesa N, De Crescenzo A, Mishra K et al: The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases. Hum Mol Genet 2012; 21: 10-25.
22. Riccio A, Sparago A, Verde G et al: Inherited and sporadic epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor. Endocr Dev 2009; 14: 1-9.
23. Cerrato F, Sparago A, Verde G et al: Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet 2008; 17: 1427-1435.
24. Sparago A, Cerrato F, Vernucci M et al: Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 2004; 36: 958-960.
25. Sparago A, Russo S, Cerrato F et al: Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. Hum Mol Genet 2007; 16: 254-264.
26. De Crescenzo A, Coppola F, Falco P et al: A novel microdeletion in the IGF2/H19 Imprinting Centre Region defines a recurrent mutation mechanism in familial Beckwith-Wiedemann syndrome. Eur J Med Genet 2011; 54: e451-e454.
27. Chang AS, Moley KH, Wangler M, Feinberg AP, Debaun MR: Association between Beckwith-Wiedemann syndrome and assisted reproductive technology: a case series of 19 patients. Fertil Steril 2005; 83: 349-354.
28. Bliek J, Gicquel C, Maas S et al: Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 2004; 145: 796-799.
29. Lam WW, Hatada I, Ohishi S et al: Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet 1999; 36: 518-523.
30. Calvello M, Tabano S, Colapietro P et al: Quantitative DNA methylation analysis improves epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. Epigenetics 2013; 8: 1053-1060.
31. Smith AC, Shuman C, Chitayat D et al: Severe presentation of Beckwith-Wiedemann syndrome associated with high levels of constitutional paternal uniparental disomy for chromosome 11p15. Am J Med Genet A 2007; 143A: 3010-3015.
32. Itoh N, Becroft DM, Reeve AE, Morison IM: Proportion of cells with paternal 11p15 uniparental disomy correlates with organ enlargement in Wiedemann-beckwith syndrome. Am J Med Genet 2000; 92: 111-116.
33. Romanelli V, Meneses HN, Fernández L et al: Beckwith-Wiedemann syndrome and uniparental disomy 11p: fine mapping of the recombination breakpoints and evaluation of several techniques. Eur J Hum Genet 2011; 19: 416-421.
34. Kalish JM, Conlin LK, Bhatti TR et al: Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy. Am J Med Genet A 2013; 161A: 1929-1939.
35. Inbar-Feigenberg M, Choufani S, Cytrynbaum C et al: Mosaicism for genome-wide paternal uniparental disomy with features of multiple imprinting disorders: diagnostic and management issues. Am J Med Genet A 2013; 161A: 13-20.
36. Halliday J, Oke K, Breheny S, Algar E, J Amor D: Beckwith-Wiedemann syndrome and IVF: a case-control study. Am J Hum Genet 2004; 75: 526-528.
37. Sutcliffe AG, Peters CJ, Bowdin S et al: Assisted reproductive therapies and imprinting disorders-a preliminary British survey. Hum Reprod 2006; 21: 1009-1011.
38. Hiura H, Okae H, Miyauchi N et al: Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies. Hum Reprod 2012; 27: 2541-2548.
39. Kupka MS, Ferraretti AP, de Mouzon J et al: ARTAssisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE. Hum Reprod 2014; 29: 2099-2113.
40. Weksberg R, Nishikawa J, Caluseriu O et al: Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 2001; 10: 2989-3000.
41. Cohen MMJr: Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 2005; 8: 287-304.
42. Cappuccio G, De Crescenzo A, Ciancia G et al: Giant breast tumors in a patient with Beckwith-Wiedemann syndrome. Am J Med Genet A 2014; 164A: 182-185.
43. McNeil DE, Brown M, Ching A, DeBaun MR: Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model. Med Pediatr Oncol 2001; 37: 349-356.
44. Scott RH, Walker L, Olsen ØE et al: Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child 2006; 91: 995-999.
45. Mussa A, Pagliardini S, Paglirdini V et al: Alpha-fetoprotein assay on dried blood spot for hepatoblastoma screening in children with overgrowth-cancer predisposition syndromes. Pediatr Res 2014; 76: 544-548.
46. Mussa A, Ferrero GB, Ceoloni B et al: Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome. Eur J Pediatr 2011; 170: 1407-1411.
47. Zarate YA, Mena R, Martin LJ et al: Experience with hemihyperplasia and Beckwith- Wiedemann syndrome surveillance protocol. Am J Med Genet A 2009; 149A: 1691-1697.